Supporting Information

Additional Experimental Details
Isolation of GdFFD neurons
The pedal ganglia were dissected and incubated in 1% (w/v) protease (type IX, Bacterial; Sigma P8811) (Sigma-Aldrich, St. Louis, MO, USA) in artificial sea water (ASW: 460 mM NaCl, 10 mM KCl, 10 mM CaCl 2 , 22 mM MgCl 2 , 26 mM MgSO 4 , 2.5 mM NaHCO 3 , and 10 mM HEPES, pH 7.7) supplemented with antibiotics (penicillin G, gentamycin, and streptomycin) and maintained at 34 °C for 30 min to loosen the connective tissue sheath. Following a 1 h rinse in ASW with antibiotics to remove the bulk of the protease, the ganglia were stretched onto a silicone elastomer (Sylgard, Dow Corning, Midland, MI, USA) layer in a Petri dish containing 3-4 mL of the ASW/antibiotic medium using 0.15 mm diameter tungsten needles (WPI, Sarasota, FL, USA); the connective tissue was surgically removed to expose neurons.
Clusters of GFFD-expressing neurons were identified according to their relative position to prominent morphological landmarks in the ganglion and excised with tungsten needles. The clusters were quickly transferred via a plastic micropipette filled with Milli-Q water to remove excess salts and deposited onto the MALDI target. Excess liquid was aspirated from the target, and spot-to-spot cell transfers were performed for sampling of individual neurons as described previously.
1,2 Matrix consisting of 0.5 μL of 2,5-dihydroxybenzoic acid (Sigma-Aldrich), 50 mg/mL in 50% acetone (Thermo Fisher Scientific, Waltham, MA, USA) was added to each spot. An equal volume of matrix and 1 mg/mL synthetic peptides dissolved in water were mixed and deposited on the target.
LC isolation of potential DAACPs
Separation methods were optimized based on the characteristics of a particular peptide and its co-eluents. All LC-grade solvents were purchased from Thermo Fisher Scientific.
For endogenous GYFD, two stages of analytic scale LC were employed using a Breeze 2 HPLC instrument (Waters, Milford, MA, USA). In the first stage, a reversed-phase Waters XSELECT CSH C18 column (3. For endogenous SYADSKDEESNAALSDFA, two stages of analytic scale LC using the Breeze 2 were employed.
In the first stage, a reversed-phase Waters XSELECT CSH C18 column (3.5 µm particle size, 4.6 mm ID × 150 mm) was The gradient was dropped from 80% B to 5% B at the end of the 110-min run. In the second stage, a reversed-phase Waters Atlantis T3 column (5 µm particle size, 2.1 mm ID × 150 mm) was used with the following: Buffer A: H 2 O.
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Buffer B: ACN. Flow rate 400 µL/min. The gradient started with 2% B for 5 min, rising to 5% B in 5 min, then 70% B in 60 min, then 90% B in 15 min and held for 5 min. The gradient was dropped from 90% B to 2% B at the end of the 100-min run.
MS and MS/MS parameters for LC-tandem mass spectrometry (MS/MS)
The mass spectrometer used was an amaZon speed ETD (Bruker Daltonics, Billerica, MA). The MS data was acquired in positive ion/enhanced resolution mode. The mass range scanned was 300 m/z to 2800 m/z. The MS/MS data was acquired in a data-dependent manner, where the three most intense precursor ions were selected for MS/MS fragmentation followed by their active exclusion from MS/MS for 0.50 min after 2 spectra each.
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The use of DCl/D 2 O for acid hydrolysis and its effect on the detection of labeled amino acids
Many peptides are present at low levels in biological samples, making MRM useful for detecting the peptide's constituent D-amino acids after acid hydrolysis because of MRM's excellent signal-to-noise ratio. However, during acid hydrolysis a low rate of amino acid racemization occurs. This produces D-amino acids, 3 which may lead to the incorrect conclusion of D-amino acids being present in the original sample. As a solution to this problem, the reactions were carried out in 6 
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An interesting observation was found for Tyrosine (Tyr), which was seen to have a different molecular weight than expected by only Tyr + label. This observation did not affect the retention time of the labeled L-or D-Tyr in the MRM that did not undergo hydrolysis ( Figure S2 ). Tyr can be substituted with chloride during acid hydrolysis; rapid vapor phase hydrolysis is meant to help prevent this phenomenon. A shift of +1 Dalton may be expected due to random racemization during deuterium-assisted acid hydrolysis. However, no racemized residue was detected in the +2 Dalton channel, so it is unlikely that the deuteron is on the alpha carbon of the amino acid (which would result in racemization).
In addition, these amino acids were in solutions that were not deuterated following deuterium hydrolysis, so the deuteron is not the result of readily exchangeable hydrogens. Rather, the deuteron may result from a substitution reaction in the ortho position on both sides, as has been noted with chloride substitutions on Tyr while using acid chlorides. No shift was observed in Tyr's molecular weight following HCl-based hydrolysis ( Figure S2 ).
For Marfey's Reagent-based labeling, the L-form was observed to always elute before the D-form, presumably due to the fixed structure of the tag where the L-amino acid's side chain will be in a trans formation with the -CH 3 of Lalanine amide (already on the tag) compared to the plane of the benzene ring on the derivatization reagent, whereas the Damino acid's side chain will be in a cis formation with the -CH 3 of L-alanine amide compared to the plane of the benzene ring on the derivatization reagent.
15,16
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GdYFD, but not SdYADSKDEESNAALSDFA, is active in the feeding and locomotor networks of Aplysia
In the first set of experiments with cerebral and buccal ganglia, we examined if the peptides could elicit feeding motor programs. We found that under resting conditions ( Figure 5A1 ), there are few spontaneous motor programs (note the absence of bursts in I2). However, upon perfusion of both 10 -6 M and 10 -5 M GdYFD, spontaneous motor programs occurred at an increased rate in a concentration-dependent manner ( Figure 5A2 , A4, F 3,21 = 32.81, p < 0.0001, n = 8).
Interestingly, the motor programs are mostly egestive as radula closer B8 fired primarily during protraction (open bar) ( Figure 5A2 ). In contrast, GYFD had no obvious effects (n = 3). In addition, neither SdYADSKDEESNAALSDFA (n = 3), nor its all L-amino acid epimer (n = 3), had any observable effects on the activity of the cerebral and buccal ganglia.
Previously, we have shown that GdFFD also promotes egestive programs. 17 Consistently, B65, an interneuron that promotes the generation of egestive programs, 18 was strongly active during the spontaneously generated programs in the presence of both GdFFD (see Figure 8B of Bai et al 2013 17 ) and GdYFD ( Figure 5A2 ). To determine if these two peptides might act directly on B65 to promote the generation of egestive programs, we examined if both peptides affected B65
excitability. For this, we applied 3-s current pulses every 30 s in B65 in high-divalent saline, which was used to curtail polysynaptic connections. We then perfused 10 -6 M and 10 -5 M peptides, and found that both GdFFD (
Figure 5B 22.34 ± 4.92 s). Perfusion of 10 -6 M GdYFD also slightly shortened retraction duration, but the effects were not statistically significant ( Figure 5E5 , F 2,6 = 2.35, p > 0.05; retraction value at 100%: 7.38 ± 1.06 s). In addition, the programs appeared to be less ingestive because B8 frequency during protraction increased somewhat (although not statistically significant, Figure 5E6 , F 2,6 = 1.97, p > 0.05; protraction frequency value at 100%: 3.88 ± 0.70 Hz), and B8 frequency during retraction decreased ( Figure 5E7 , F 2,6 = 7.89, p < 0.05; retraction frequency value at 100%: 10.39 ± 0.51
Hz).
We also tested the effects of GdYFD on the locomotor network. First, we examined if the peptides could elicit activity in the parapedal commissural nerve (PPCN) of the isolated nervous systems of cerebral and pedal ganglia. We Figure   S7B7 , F 3,15 = 10.1, p < 0.001, n = 6). These effects are similar to the effects of GdFFD described earlier. 19 In addition,
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neither SdYADSKDEESNAALSDFA (n = 3) nor its all L-amino acid epimer (n = 3) had any observable effects on the activity of cerebral and pedal ganglia.
Because we showed that the increase in the frequency between bursts in GdFFD appeared to be detrimental to locomotor behavior, which acted to reduce locomotion in intact animals, 19 we also tested the effects of GdYFD on the locomotor behavior. Initially we used 10 -7 M GdYFD and found that it reduced locomotor velocity but the effects were not statistically significant. We then increased the concentration to 10 -6 M GdYFD, and found that it reduced locomotor velocity significantly ( Figure S7 ). Using normalized data (natural logarithm of velocity) as described in the previous study, 19 we found that whereas injection of ASW had no effects on locomotion (natural logarithm of velocity, before: 8.53
±0.26; after: 8.28 ±0.47; two tailed t-test, p > 0.05, n = 4), injection of GdYFD significantly reduced locomotion (natural logarithm of velocity, before: 8.52 ±0.42; after: 5.95 ±0.21; two tailed t-test, p < 0.05, n = 4). Figure S1 ). (A) The expected molecular weight for Tyr + label yields a large peak in HCl-assisted hydrolysis, but almost no peak in DCl-assisted hydrolysis. (B) In the channel for Tyr + label + 1 Da, there is still almost no molecular species seen in DCl-assisted hydrolysis, even though a single deuteron would lead to Tyr being detected in this channel. There is still a substantial peak for HCl-assisted hydrolysis of Tyr, but this can result from naturally occurring carbon and hydrogen isotopes. (C) In the channel for Tyr + label + 2Da, there is a large peak in the DCl-assisted hydrolysis, which accounts for the majority of this species. This is an unracemized (L-Tyr) species.
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Meanwhile, little (< 5% of intensity of original species on the left) is detected for Tyr in HCl-assisted hydrolysis. GFFG was detected as GFFamide in Figure S5 . GDAS has not been detected. GFFD and YYGS have been detected previously. 17 
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